Home › Agent Hub › Agent Tools › Part D coverage by drug › Restasis
Agent Tools
Restasis is a brand of cyclosporine. What agents check before quoting it: how many 2027 Part D plans cover it, on which tier, with what restrictions and copays, by plan type, carrier and state.
In 2027, 3,101 of 5,492 Medicare Part D and Medicare Advantage drug plans (56.5%) list Restasis on their formulary, across 113 of 286 formularies. The most common placement is tier 3 (3,067 plans, 98.9% of those covering it). 0 of the covering plans require prior authorization (0%), 0 step therapy and 2,132 a quantity limit. Generic cyclosporine is on 5,492 of 5,492 plans (100%).
164 covering plans charge a flat copay for a 30-day supply at a preferred retail pharmacy after the deductible — median $38, 54 of them $0; 2,937 charge coinsurance instead — median 22% of the drug's cost. Once a member's out-of-pocket drug spending reaches $2,400 in 2027, covered drugs cost $0 for the rest of the year.
2026: 3,304 of 5,496 plans covered it (60.1%); 2027: 3,101 of 5,492 (56.5%).
Of 4,367 plans offered in both years, 21 added it to the formulary and 274 dropped it.
Among plans covering it both years, 14 moved it to a higher tier and 1 to a lower one; 0 added prior authorization and 0 removed it.
| Tier | Plans |
|---|---|
| Tier 1 | 34 |
| Tier 3 | 3,067 |
| Plan type | Plans covering | Share | Prior auth |
|---|---|---|---|
| Stand-alone Part D (PDP) | 69 of 323 | 21.4% | 0% |
| Medicare Advantage with drugs (MA-PD) | 1,834 of 3,200 | 57.3% | 0% |
| Special needs plans (SNP) | 1,198 of 1,969 | 60.8% | 0% |
| Carrier | Plans covering | Usual tier | Prior auth |
|---|---|---|---|
| Humana | 0 of 846 | No tier listed | 0 |
| UnitedHealthcare | 796 of 830 | Tier 3 | 0 |
| Devoted Health | 728 of 728 | Tier 3 | 0 |
| Aetna Medicare | 631 of 631 | Tier 3 | 0 |
| Wellcare | 0 of 268 | No tier listed | 0 |
| HealthSpring | 0 of 226 | No tier listed | 0 |
| Kaiser Permanente | 0 of 112 | No tier listed | 0 |
| SCAN Health Plan | 0 of 83 | No tier listed | 0 |
| Highmark Blue Cross Blue Shield or Highmark Blue Shield | 80 of 80 | Tier 3 | 0 |
| Alignment Health Plan | 0 of 77 | No tier listed | 0 |
| Anthem Blue Cross and Blue Shield | 74 of 74 | Tier 3 | 0 |
| Wellpoint | 63 of 63 | Tier 3 | 0 |
| Priority Health Medicare | 40 of 40 | Tier 3 | 0 |
| CarePlus Health Plans, Inc. | 0 of 37 | No tier listed | 0 |
| Zing Health | 36 of 36 | Tier 3 | 0 |
| Capital Blue Cross | 0 of 35 | No tier listed | 0 |
| Prominence Health Plan | 29 of 29 | Tier 3 | 0 |
| Medica | 0 of 27 | No tier listed | 0 |
| Anthem HealthKeepers | 26 of 26 | Tier 3 | 0 |
| Blue Cross Blue Shield of Michigan | 26 of 26 | Tier 3 | 0 |
| State | Plans covering | Share |
|---|---|---|
| Alabama | 66 of 114 | 57.9% |
| Alaska | 2 of 9 | 22.2% |
| American Samoa | 1 of 1 | 100% |
| Arizona | 84 of 147 | 57.1% |
| Arkansas | 44 of 85 | 51.8% |
| California | 136 of 397 | 34.3% |
| Colorado | 55 of 106 | 51.9% |
| Connecticut | 39 of 54 | 72.2% |
| Delaware | 26 of 43 | 60.5% |
| District of Columbia | 8 of 12 | 66.7% |
| Florida | 265 of 545 | 48.6% |
| Georgia | 65 of 149 | 43.6% |
| Guam | 1 of 1 | 100% |
| Hawaii | 32 of 50 | 64% |
| Idaho | 26 of 45 | 57.8% |
| Illinois | 73 of 132 | 55.3% |
| Indiana | 91 of 138 | 65.9% |
| Iowa | 42 of 64 | 65.6% |
| Kansas | 50 of 84 | 59.5% |
| Kentucky | 60 of 121 | 49.6% |
| Louisiana | 60 of 125 | 48% |
| Maine | 29 of 52 | 55.8% |
| Maryland | 23 of 49 | 46.9% |
| Massachusetts | 78 of 89 | 87.6% |
| Michigan | 135 of 182 | 74.2% |
| Minnesota | 29 of 63 | 46% |
| Mississippi | 51 of 104 | 49% |
| Missouri | 104 of 170 | 61.2% |
| Montana | 5 of 27 | 18.5% |
| Nebraska | 29 of 51 | 56.9% |
| Nevada | 51 of 100 | 51% |
| New Hampshire | 12 of 25 | 48% |
| New Jersey | 44 of 73 | 60.3% |
| New Mexico | 45 of 68 | 66.2% |
| New York | 161 of 215 | 74.9% |
| North Carolina | 100 of 176 | 56.8% |
| North Dakota | 12 of 26 | 46.2% |
| Northern Mariana Islands | 1 of 1 | 100% |
| Ohio | 99 of 171 | 57.9% |
| Oklahoma | 38 of 81 | 46.9% |
| Oregon | 38 of 92 | 41.3% |
| Pennsylvania | 183 of 323 | 56.7% |
| Puerto Rico | 19 of 64 | 29.7% |
| Rhode Island | 22 of 29 | 75.9% |
| South Carolina | 43 of 89 | 48.3% |
| South Dakota | 14 of 30 | 46.7% |
| Tennessee | 109 of 156 | 69.9% |
| Texas | 232 of 407 | 57% |
| U.S. Virgin Islands | 1 of 1 | 100% |
| Utah | 28 of 53 | 52.8% |
| Vermont | 3 of 14 | 21.4% |
| Virginia | 83 of 144 | 57.6% |
| Washington | 58 of 114 | 50.9% |
| West Virginia | 35 of 69 | 50.7% |
| Wisconsin | 55 of 96 | 57.3% |
| Wyoming | 3 of 13 | 23.1% |
Medicare Part D paid for 2,268,745 30-day fills of Restasis in 2024 for about 498,466 enrollees, at an average total cost of $596.04 per 30-day fill (CMS Part D Prescribers by Geography and Drug, national).
Price Restasis and the rest of a client's list on every plan in their county.
Estimate Restasis costs by plan
Free tools for licensed insurance agents. Data from CMS public files; verify with plan documents before advising a client.
Counts are over every Medicare Advantage drug plan and stand-alone Part D plan in the CMS monthly formulary files, excluding employer plans. A plan counts as covering a drug when any strength or form of it is on the plan’s formulary; the tier, prior authorization, step therapy and quantity limit shown are the most favorable version on that formulary. Copays are for a 30-day supply at a preferred retail pharmacy after the deductible. This is a reference for licensed agents, not a plan recommendation; verify with the plan’s formulary before advising a client. Source: CMS Part D formulary files (release 10/08/2026). CMS formulary data.